A Half-Log Increase in BCR-ABL RNA Predicts a Higher Risk of Relapse in Patients with Chronic Myeloid Leukemia with an Imatinib-Induced Complete Cytogenetic ResponseRichard D. Press, Michael W. Deininger, Stephanie G. Willis et al.|Clinical Cancer Research|2007Cited by 123
Development and Validation Of Highly Sensitive Mrdx BCR-ABL Test For Monitoring Deep Molecular Response In Patients With Chronic Myeloid LeukemiaJulie Toplin, Chad Galderisi, Kristy Drafahl et al.|Blood|2013Cited by 2